article thumbnail

DataScience.com Acquired By Oracle

socalTECH

Culver City-based DataScience.com , a developer of data science software led by serial entrepreneur Ian Swanson, has been acquired by Oracle , the companies said on Wednesday. Financial details of the acquisition were not announced. READ MORE>>.

Oracle 113
article thumbnail

Master of Customer Acquisition, Matt Coffin, On Startups …

Both Sides of the Table

Matt was one of my inspirations behind Launchpad LA (yes, we’re going to have a program in 2011 – news very, very soon). He is very hands-on and helpful – especially for any company looking into customer acquisition. o CPM model gave him control over the information in the acquisition cycle so he focused on that. -

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

American Entrepreneurs – Be Happy You Are Not In Spain

InfoChachkie

He founded Alpha Origins in 2011. Fredi''s email is worth reading, as it reinforces how lucky American entrepreneurs truly are. However, from an entrepreneur''s viewpoint, the philosophical distance can be measured in light years. Geographically, the distance between Spain and the US is about 4,715 miles. Fredi''s Plea.

article thumbnail

How TVC Aims At Acquisitions, Not IPOs, with Jeb Spencer

socalTECH

We thought it might be interesting to talk with one of the fund's managing directors, Jeb Spencer about the fund's success in technology investments, plus how it managed to raise another fund in this kind of environment, plus its unique goal of getting companies to an acquisition--and not an IPO.

article thumbnail

Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases

Xconomy

Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmaceuticals. Grey, who was president and CEO of Lumuna from 2011 through its 2014 acquisition by Irish drugmaker Shire (now part of Japan’s Takeda Pharmaceutical.

article thumbnail

Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

Xconomy

When a group of scientists from Amira Pharmaceuticals wanted to start a new biotech after the company’s 2011 acquisition by Bristol-Myers Squibb , Celgene provided seed funding. Rob Williamson, a longtime biotech entrepreneur, joined PharmAkea as CEO in 2013 after the company formed its “build-to-buy”-style.

article thumbnail

An IPO Exit Strategy Puts the Entrepreneur at Risk

Startup Professionals Musings

Many entrepreneurs still dream of “going public,” making billions of dollars, and playing with the big boys. IPOs in 2008, the market was up to a still trivial 159 in 2011. With the more popular Merger & Acquisition (M&A) exit strategy, the control stays with the new entity. After a record low of 39 U.S.